This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Acne Vulgaris
and you are
between 16 and 65
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study is designed to investigate the efficacy, safety and tolerability of MTC896 Gel in subjects with acne. In this study, MTC896 Gel will be applied at 3 concentrations, twice daily (bid) for 12 weeks and compared against a vehicle control.

Provided treatments

  • Drug: 0.375% (w/w) MTC896 Gel
  • Drug: 0.75% (w/w) MTC896 Gel
  • Drug: 1.5% (w/w) MTC896 Gel
  • Drug: Vehicle Control Gel
Tris trial is registered with FDA with number: NCT02395549. The sponsor of the trial is Mimetica Pty Limited and it is looking for 364 volunteers for the current phase.
Official trial title: